Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Mikolaj Swierczynski, Adam Makaro, Agata Grochowska & Maciej Salaga. (2023) Pharmacological approaches to treat intestinal pain. Expert Review of Clinical Pharmacology 16:4, pages 297-311.
Read now
Read now
Jennifer Jones, Anthony Lembo, Joel Heidelbaugh, Louis Kuritzky & Brian Lacy. (2021) Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Current Medical Research and Opinion 37:4, pages 567-578.
Read now
Read now
Rebecca Liu & Kyle Staller. (2020) Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives. Drug Design, Development and Therapy 14, pages 1391-1400.
Read now
Read now
Maura Corsetti & Peter Whorwell. (2017) New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline. Expert Review of Gastroenterology & Hepatology 11:4, pages 285-292.
Read now
Read now
Brian E Lacy. (2016) Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. International Journal of General Medicine 9, pages 7-17.
Read now
Read now
Maura Corsetti & Peter Whorwell. (2016) Novel pharmacological therapies for irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 10:7, pages 807-815.
Read now
Read now
Judy Nee, Mohammed Zakari & Anthony J Lembo. (2015) Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 16:18, pages 2781-2792.
Read now
Read now
Simona Deiana, Tommaso Gabbani, Siro Bagnoli & Vito Annese. (2015) Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opinion on Emerging Drugs 20:2, pages 247-261.
Read now
Read now
Michael Camilleri. (2013) Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 14:9, pages 1151-1160.
Read now
Read now
Ashkan Farhadi, Keith Bruninga, Jeremy Fields & Ali Keshavarzian. (2001) Irritable bowel syndrome: an update on therapeutic modalities. Expert Opinion on Investigational Drugs 10:7, pages 1211-1222.
Read now
Read now
Articles from other publishers (104)
David Gunn, Rabia Topan, Lorna Barnard, Ron Fried, Ivana Holloway, Richard Brindle, Maura Corsetti, Mark Scott, Adam Farmer, Kapil Kapur, David Sanders, Maria Eugenicos, Nigel Trudgill, Peter Whorwell, John Mclaughlin, Ayesha Akbar, Lesley Houghton, Phil G. Dinning, Qasim Aziz, Alexander C. Ford, Amanda J. Farrin & Robin Spiller. (2023)
Randomised, placebo‐controlled trial and meta‐analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The
TRITON
trial
. Alimentary Pharmacology & Therapeutics 57:11, pages 1258-1271.
Crossref
Crossref
Bénédicte Caron, Subrata Ghosh, Silvio Danese & Laurent Peyrin-Biroulet. (2023) Identifying, Understanding, and Managing Fecal Urgency in Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 21:6, pages 1403-1413.e27.
Crossref
Crossref
Ankita Wal, Pranay Wal, Neha Verma, Awani Kumar Rai & Piyush Vatsha. (2023) Mechanism, Pathophysiology and Herbal Management-A Review on
Irritable Bowel Syndrome. The Natural Products Journal 13:3.
Crossref
Crossref
Gabriela Piovezani Ramos & Michael Camilleri. (2022) Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea. Digestive Diseases and Sciences 68:5, pages 1677-1690.
Crossref
Crossref
Daniel Pohl, Stephan Vavricka, Mark Fox, Ahmed Madisch, Diana Studerus, Paul Wiesel, Henriette Heinrich, Ioannis Linas, Alain Schoepfer, Alexandra Schwizer & Stephan Wildi. (2023) Häufige Magen-Darm-Beschwerden: Management der funktionellen Dyspepsie und des Reizdarm-Syndroms in der Praxis. Praxis 112:5-6, pages 304-316.
Crossref
Crossref
Uday C. Ghoshal, Sanjeev Sachdeva, Nitesh Pratap, Arun Karyampudi, Uzma Mustafa, Philip Abraham, Chetan B. Bhatt, Karmabir Chakravartty, Sujit Chaudhuri, Omesh Goyal, Govind K. Makharia, Manas Kumar Panigrahi, Prasanta Kumar Parida, Sudhanshu Patwari, Rajesh Sainani, Shine Sadasivan, M. Srinivas, Rajesh Upadhyay & Jayanthi Venkataraman. (2023) Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology. Indian Journal of Gastroenterology 42:2, pages 249-273.
Crossref
Crossref
Christoffer S. Graven-Nielsen, Cecilie S. Knoph, Tina Okdahl, Katrine L. Høyer, Klaus Krogh, Per M. Hellström & Asbjørn M. Drewes. (2023) Opioids in the Treatment of Chronic Idiopathic Diarrhea in Humans—A Systematic Review and Treatment Guideline. Journal of Clinical Medicine 12:7, pages 2488.
Crossref
Crossref
Maria Rosa Ingrosso, Gianluca Ianiro, Judy Nee, Anthony J. Lembo, Paul Moayyedi, Christopher J. Black & Alexander C. Ford. (2022) Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 56:6, pages 932-941.
Crossref
Crossref
Anthony Lembo, Shahnaz Sultan, Lin Chang, Joel J. Heidelbaugh, Walter Smalley & G. Nicholas Verne. (2022) AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea. Gastroenterology 163:1, pages 137-151.
Crossref
Crossref
Edoardo Savarino, Fabiana Zingone, Brigida Barberio, Giovanni Marasco, Filiz Akyuz, Hale Akpinar, Oana Barboi, Giorgia Bodini, Serhat Bor, Giuseppe Chiarioni, Gheorghe Cristian, Maura Corsetti, Antonio Di Sabatino, Anca Mirela Dimitriu, Vasile Drug, Dan L. Dumitrascu, Alexander C. Ford, Goran Hauser, Radislav Nakov, Nisha Patel, Daniel Pohl, Cătălin Sfarti, Jordi Serra, Magnus Simrén, Alina Suciu, Jan Tack, Murat Toruner, Julian Walters, Cesare Cremon & Giovanni Barbara. (2022) Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterology Journal 10:6, pages 556-584.
Crossref
Crossref
S Kindt, H Louis, H De Schepper, J Arts, P Caenepeel, D De Looze, A Gerkens, T Holvoet, P Latour, T Mahler, F Mokaddem, S Nullens, H Piessevaux, P Poortmans, G Rasschaert, M Surmont, H Vafa, K Van Malderen, T Vanuytsel, F Wuestenberghs & J Tack. (2022) Belgian consensus on irritable bowel syndrome. Acta Gastro Enterologica Belgica 85:2, pages 360-382.
Crossref
Crossref
Eric D. Shah, Jessica K. Salwen-Deremer, Peter R. Gibson, Jane G. Muir, Shanti Eswaran & William D. Chey. (2022) Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis. Clinical Gastroenterology and Hepatology 20:1, pages 136-144.e31.
Crossref
Crossref
Kyung Ho Song. 2022. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases
273
280
.
Judy Nee & Anthony Lembo. (2021) Review Article: Current and future treatment approaches for IBS with diarrhoea (IBS‐D) and IBS mixed pattern (IBS‐M). Alimentary Pharmacology & Therapeutics 54:S1.
Crossref
Crossref
Duc Trong Quach, Khoa Tien Vu & Khien Van Vu. (2021) Prevalence, clinical characteristics, and management of irritable bowel syndrome in Vietnam: A scoping review. JGH Open 5:11, pages 1227-1235.
Crossref
Crossref
Gregory S. Sayuk. (2021) Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology Clinics of North America 50:3, pages 611-637.
Crossref
Crossref
Christopher J Black & Alexander Charles Ford. (2021) Best management of irritable bowel syndrome. Frontline Gastroenterology 12:4, pages 303-315.
Crossref
Crossref
Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tastuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa & Kazuhiko Koike. (2021) Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. Journal of Gastroenterology 56:3, pages 193-217.
Crossref
Crossref
Esther Colomier, Joost Algera & Chloé Melchior. (2021) Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Frontiers in Pharmacology 11.
Crossref
Crossref
Eric D. Shah, Jessica K. Salwen-Deremer, Peter R. Gibson, Jane G. Muir, Shanti Eswaran & William D. Chey. (2021) Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis. MDM Policy & Practice 6:1, pages 238146832097841.
Crossref
Crossref
Xia Li, Bo Li, Jiaqi Zhang, Ting Chen, Haomeng Wu, Xiaoshuang Shi, Jinxin Ma, Jinyan Qin, Xudong Tang & Fengyun Wang. (2021) Efficacy of opioid receptor modulators in patients with irritable bowel syndrome. Medicine 100:4, pages e24361.
Crossref
Crossref
Imke Masuy, Jasper Pannemans & Jan Tack. (2020) Irritable bowel syndrome: diagnosis and management. Minerva Gastroenterologica e Dietologica 66:2.
Crossref
Crossref
Ana Isabel Ferreira, Mónica Garrido & Fernando Castro-Poças. (2020) Irritable Bowel Syndrome: News from an Old Disorder. GE - Portuguese Journal of Gastroenterology 27:4, pages 255-268.
Crossref
Crossref
Sanjeev KelkarSanjeev Kelkar. 2020. Diabetic Neuropathy and Clinical Practice. Diabetic Neuropathy and Clinical Practice
65
89
.
Rachel Vanderberg, Amy D. Lu & Jana G. Hashash. 2020. Sex- and Gender-Based Women's Health. Sex- and Gender-Based Women's Health
417
428
.
David Gunn, Ron Fried, Rabia Lalani, Amanda Farrin, Ivana Holloway, Tom Morris, Catherine Olivier, Rachael Kearns, Maura Corsetti, Mark Scott, Adam Farmer, Anton Emmanuel, Peter Whorwell, Yan Yiannakou, David Sanders, John Mclaughlin, Kapil Kapur, Maria Eugenicos, Ayesha Akbar, Nigel Trudgill, Lesley Houghton, Phil G. Dinning, Alexander C. Ford, Qasim Aziz & Robin Spiller. (2019) Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial. Trials 20:1.
Crossref
Crossref
Giovanni Dothel, Lin Chang, Wendy Shih, Maria Raffaella Barbaro, Cesare Cremon, Vincenzo Stanghellini, Fabrizio De Ponti, Emeran A. Mayer, Giovanni Barbara & Catia Sternini. (2019) µ‐opioid receptor, β‐endorphin, and cannabinoid receptor‐2 are increased in the colonic mucosa of irritable bowel syndrome patients. Neurogastroenterology & Motility 31:11.
Crossref
Crossref
Kok Ann Gwee, Sutep Gonlachanvit, Uday C Ghoshal, Andrew S B Chua, Hiroto Miwa, Justin Wu, Young-Tae Bak, Oh Young Lee, Ching-Liang Lu, Hyojin Park, Minhu Chen, Ari F Syam, Philip Abraham, Jose Sollano, Chi-Sen Chang, Hidekazu Suzuki, Xiucai Fang, Shin Fukudo, Myung-Gyu Choi, Xiaohua Hou & Michio Hongo. (2019) Second Asian Consensus on Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 25:3, pages 343-362.
Crossref
Crossref
D. N. Andreev & D. T. Dicheva. (2019) Optimizing the treatment of patients with irritable bowel syndrome: focus on increased compliance. Medical Council:3, pages 118-124.
Crossref
Crossref
Alexander C. Ford. 2019. Evidence-based Gastroenterology and Hepatology 4e. Evidence-based Gastroenterology and Hepatology 4e
306
331
.
Paul Moayyedi, Christopher N Andrews, Glenda MacQueen, Christina Korownyk, Megan Marsiglio, Lesley Graff, Brent Kvern, Adriana Lazarescu, Louis Liu, William G Paterson, Sacha Sidani & Stephen Vanner. (2019) Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). Journal of the Canadian Association of Gastroenterology 2:1, pages 6-29.
Crossref
Crossref
Jae Hak KimSam Ryong Jee. (2019) Irritable Bowel Syndrome. The Korean Journal of Gastroenterology 73:2, pages 84.
Crossref
Crossref
Maximilian Kordes & Marco Gerling. (2019) Variations in the management of diarrhoea induced by cancer therapy: results from an international, cross-sectional survey among European oncologists. ESMO Open 4:6, pages e000607.
Crossref
Crossref
Michael Camilleri. (2018) Management Options for Irritable Bowel Syndrome. Mayo Clinic Proceedings 93:12, pages 1858-1872.
Crossref
Crossref
J Pannemans & M Corsetti. (2018) Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?. Current Opinion in Pharmacology 43, pages 53-58.
Crossref
Crossref
Alexander C. Ford, Paul Moayyedi, William D. Chey, Lucinda A. Harris, Brian E. Lacy, Yuri A. Saito & Eamonn M. M. Quigley. (2018) American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. American Journal of Gastroenterology 113, pages 1-18.
Crossref
Crossref
Kyung Ho Song, Hye-Kyung Jung, Hyun Jin Kim, Hoon Sup Koo, Yong Hwan Kwon, Hyun Duk Shin, Hyun Chul Lim, Jeong Eun Shin, Sung Eun Kim, Dae Hyeon Cho, Jeong Hwan Kim & Hyun Jung Kim. (2018) Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. Journal of Neurogastroenterology and Motility 24:2, pages 197-215.
Crossref
Crossref
Victor Chedid, Priya Vijayvargiya & Michael Camilleri. (2018) Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline. Clinical Gastroenterology and Hepatology 16:3, pages 336-338.
Crossref
Crossref
A. Wasilewski, A. Misicka, M. Sacharczuk & J. Fichna. (2018) Prosecretory effect of loperamide in ileal and colonic mucosae of mice displaying high or low swim stress-induced analgesia associated with high and low endogenous opioid system activity. Neurogastroenterology & Motility 30:2, pages e13166.
Crossref
Crossref
Kenneth Barshop & Kyle Staller. (2017) Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy. Therapeutic Advances in Chronic Disease 8:11, pages 153-160.
Crossref
Crossref
Michael Camilleri & Alexander Ford. (2017) Pharmacotherapy for Irritable Bowel Syndrome. Journal of Clinical Medicine 6:11, pages 101.
Crossref
Crossref
Michael Camilleri, Anthony Lembo & David A. Katzka. (2017) Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits. Clinical Gastroenterology and Hepatology 15:9, pages 1338-1349.
Crossref
Crossref
Brian E Lacy, William D Chey, Brooks D Cash, Anthony J Lembo, Leonard S Dove & Paul S Covington. (2017) Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. American Journal of Gastroenterology 112:6, pages 924-932.
Crossref
Crossref
Ying Wu, Beiyan Zou, Lingli Liang, Min Li, Yuan-Xiang Tao, Haibo Yu, Xiaoliang Wang & Min Li. (2017) Loperamide inhibits sodium channels to alleviate inflammatory hyperalgesia. Neuropharmacology 117, pages 282-291.
Crossref
Crossref
Emma P Halmos. (2017) When the low FODMAP diet does not work. Journal of Gastroenterology and Hepatology 32, pages 69-72.
Crossref
Crossref
Susan Lucak, Lin Chang, Albena Halpert & Lucinda A. Harris. (2016) Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therapeutic Advances in Gastroenterology 10:2, pages 253-275.
Crossref
Crossref
Longtu Chen, Sheikh J. Ilham & Bin Feng. (2017) Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesthesiology and Pain Medicine 7:2.
Crossref
Crossref
Chan Hyuk Park & Dong Soo Han. (2017) Pharmacotherapy of irritable bowel syndrome. Journal of the Korean Medical Association 60:1, pages 57.
Crossref
Crossref
Maciej Sałaga & Paula Mosińska. 2017. Introduction to Gastrointestinal Diseases Vol. 1. Introduction to Gastrointestinal Diseases Vol. 1
43
61
.
Brian E. Lacy, Fermín Mearin, Lin Chang, William D. Chey, Anthony J. Lembo, Magnus Simren & Robin Spiller. (2016) Bowel Disorders. Gastroenterology 150:6, pages 1393-1407.e5.
Crossref
Crossref
Hans Törnblom. (2015) Treatment of gastrointestinal autonomic neuropathy. Diabetologia 59:3, pages 409-413.
Crossref
Crossref
Anthony J. Lembo, Brian E. Lacy, Marc J. Zuckerman, Ron Schey, Leonard S. Dove, David A. Andrae, J. Michael Davenport, Gail McIntyre, Rocio Lopez, Lisa Turner & Paul S. Covington. (2016) Eluxadoline for Irritable Bowel Syndrome with Diarrhea. New England Journal of Medicine 374:3, pages 242-253.
Crossref
Crossref
Xiaofang Lu, Shengsheng Zhang, Cheng Yang, Zhengfang Wang, Luqing Zhao, Zhenyu Wu & Jing Xie. (2016)
Effect of TongXie-YaoFang on Cl
−
and
Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats
. Evidence-Based Complementary and Alternative Medicine 2016, pages 1-8.
Crossref
Crossref
B. E. Lacy. (2016) Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS. Neurogastroenterology & Motility 28:1, pages 26-35.
Crossref
Crossref
Michael Camilleri & Alexander C. Ford. 2017. Gastrointestinal Pharmacology. Gastrointestinal Pharmacology
75
113
.
Judy Nee, Mohammed Zakari & Anthony J. Lembo. (2015) Novel Therapies in IBS-D Treatment. Current Treatment Options in Gastroenterology 13:4, pages 432-440.
Crossref
Crossref
Seyed Reza Abtahi & Parvin Zareian. (2015) Assessment of Consensus-Based Pharmacological Therapies in Irritable Bowel Syndrome. Journal of Archives in Military Medicine 3:3.
Crossref
Crossref
Azadeh Rezvan, Sharon Jakus-Waldman, Maher A. Abbas, Tajnoos Yazdany & John Nguyen. (2015) Review of the Diagnosis, Management and Treatment of Fecal Incontinence. Female Pelvic Medicine & Reconstructive Surgery 21:1, pages 8-17.
Crossref
Crossref
Shin Fukudo, Hiroshi Kaneko, Hirotada Akiho, Masahiko Inamori, Yuka Endo, Toshikatsu Okumura, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Toshimi Chiba, Kenji Furuta, Shigeru Yamato, Tetsuo Arakawa, Yoshihide Fujiyama, Takeshi Azuma, Kazuma Fujimoto, Tetsuya Mine, Soichiro Miura, Yoshikazu Kinoshita, Kentaro Sugano & Tooru Shimosegawa. (2014) Evidence-based clinical practice guidelines for irritable bowel syndrome. Journal of Gastroenterology 50:1, pages 11-30.
Crossref
Crossref
Lin Chang, Anthony Lembo & Shahnaz Sultan. (2014) American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome. Gastroenterology 147:5, pages 1149-1172.e2.
Crossref
Crossref
Christopher T. McNabb, Michelle M. White, Amber L. Harris & Perry N. Fuchs. (2014) The elusive rat model of conditioned placebo analgesia. Pain 155:10, pages 2022-2032.
Crossref
Crossref
Jose L. Barboza, Nicholas J. Talley & Baharak Moshiree. (2014) Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome. Drugs 74:16, pages 1849-1870.
Crossref
Crossref
Alexander C Ford, Paul Moayyedi, Brian E Lacy, Anthony J Lembo, Yuri A Saito, Lawrence R Schiller, Edy E Soffer, Brennan M R Spiegel & Eamonn M M Quigley. (2014) American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation. American Journal of Gastroenterology 109, pages S2-S26.
Crossref
Crossref
Rosa LS Soares. (2014) Irritable bowel syndrome: A clinical review. World Journal of Gastroenterology 20:34, pages 12144.
Crossref
Crossref
Katy E. Trinkley & Milap C. Nahata. (2014) Medication Management of Irritable Bowel Syndrome. Digestion 89:4, pages 253-267.
Crossref
Crossref
Magnus Simrén & Hans TörnblomMagnus Simrén & Hans Törnblom. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
194
200
.
Magnus Simrén & Hans TörnblomEleni Athanasakos & Anton Emmanuel. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
171
193
.
Magnus Simrén & Hans TörnblomMichael Camilleri. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management
105
129
.
Hans Törnblom & Magnus Simrén. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome
277
299
.
Magdy El-Salhy, Doris Gundersen, Jan Gunnar Hatlebakk & Trygve Hausken. (2012) Irritable bowel syndrome: treatment options. Clinical Practice 9:5, pages 591-600.
Crossref
Crossref
Jan Tack. (2012) Functional Diarrhea. Gastroenterology Clinics of North America 41:3, pages 629-637.
Crossref
Crossref
Robin C. Spiller & W. Grant Thompson. (2012) [NO TITLE AVAILABLE]. Arquivos de Gastroenterologia 49:suppl 1, pages 39-50.
Crossref
Crossref
William D. Chey, Monthira Maneerattaporn & Richard Saad. (2011) Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome. Gut and Liver 5:3, pages 253-266.
Crossref
Crossref
K. E. Trinkley & M. C. Nahata. (2011) Treatment of irritable bowel syndrome. Journal of Clinical Pharmacy and Therapeutics 36:3, pages 275-282.
Crossref
Crossref
Richard J. Saad. (2011) Peripherally Acting Therapies for the Treatment of Irritable Bowel Syndrome. Gastroenterology Clinics of North America 40:1, pages 163-182.
Crossref
Crossref
Joong Goo KwonKyung Sik ParkJung Ho ParkJae Myung ParkCheol Hee ParkKwang Jae LeeHyo-Jin ParkJong Chul Rhee. (2011) Guidelines for the Treatment of Irritable Bowel Syndrome. The Korean Journal of Gastroenterology 57:2, pages 82.
Crossref
Crossref
Sarah Khan & Lin Chang. (2010) Diagnosis and management of IBS. Nature Reviews Gastroenterology & Hepatology 7:10, pages 565-581.
Crossref
Crossref
Alexander C Ford, Paul Moayyedi & Nicholas J Talley. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
355
376
.
Kok-Ann Gwee, Young-Tae Bak, Uday Chand Ghoshal, Sutep Gonlachanvit, Oh Young Lee, Kwong Ming Fock, Andrew Seng Boon Chua, Ching-Liang Lu, Khean-Lee Goh, Chomsri Kositchaiwat, Govind Makharia, Hyo-Jin Park, Full-Young Chang, Shin Fukudo, Myung-Gyu Choi, Shobna Bhatia, Meiyun Ke, Xiaohua Hou & Michio Hongo. (2010) Asian consensus on irritable bowel syndrome. Journal of Gastroenterology and Hepatology 25:7, pages 1189-1205.
Crossref
Crossref
Robin C Spiller & Grant W Thompson. (2010) Bowel Disorders. American Journal of Gastroenterology 105:4, pages 775-785.
Crossref
Crossref
Nicholas J. Talley. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
2091
2104.e6
.
Brian E. Lacy, Kirsten Weiser & Ryan De Lee. (2009) Review: The treatment of irritable bowel syndrome. Therapeutic Advances in Gastroenterology 2:4, pages 221-238.
Crossref
Crossref
Lawrence J. Brandt, William D. Chey, Amy E. Foxx-Orenstein, Eamonn M.M. Quigley, Lawrence R. Schiller, Philip S. Schoenfeld, Brennan M. Spiegel, Nicholas J. Talley & Paul Moayyedi. (2009) An Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome. American Journal of Gastroenterology 104, pages S8-S35.
Crossref
Crossref
R. C. Spiller. 2009. Intestinal Disorders. Intestinal Disorders
42
53
.
Christopher W Hammerle & Christina M Surawicz. (2008) Updates on treatment of irritable bowel syndrome. World Journal of Gastroenterology 14:17, pages 2639.
Crossref
Crossref
Fermín Mearin. (2007) Tratamiento farmacológico del síndrome del intestino irritable: una necesidad no cubierta. Gastroenterología y Hepatología 30:3, pages 130-137.
Crossref
Crossref
Revital Kariv, Elisa Tiomny, Roman Grenshpon, Roy Dekel, Galit Waisman, Yehuda Ringel & Zamir Halpern. (2006) Low-Dose Naltreoxone for the Treatment of Irritable Bowel Syndrome: A Pilot Study. Digestive Diseases and Sciences 51:12, pages 2128-2133.
Crossref
Crossref
H. Mönnikes, M. Schmidtmann & I. R. van der Voort. (2006) Arzneimitteltherapie des ReizdarmsyndromsDrug therapy for irritable bowel syndrome. Der Internist 47:10, pages 1073-1083.
Crossref
Crossref
J. TACK, M. FRIED, L. A. HOUGHTON, J. SPICAK & G. FISHER. (2006) Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Alimentary Pharmacology and Therapeutics 24:2, pages 183-205.
Crossref
Crossref
R. HEADING, K. BARDHAN, S. HOLLERBACH, A. LANAS & G. FISHER. (2006) Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome - a European perspective. Alimentary Pharmacology and Therapeutics 24:2, pages 207-236.
Crossref
Crossref
Howard Y. Chang, Eoin C. Kelly & Anthony J. Lembo. (2006) Current gut-directed therapies for irritable bowel syndrome. Current Treatment Options in Gastroenterology 9:4, pages 314-323.
Crossref
Crossref
S. D. Kuiken, G. N. Tytgat & G. E. Boeckxstaens. (2005) Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders - the clinical evidence. Alimentary Pharmacology and Therapeutics 21:6, pages 633-651.
Crossref
Crossref
D. Lesbros-Pantoflickova, P. Michetti, M. Fried, C. Beglinger & A. L. Blum. (2004) Meta-analysis: the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 20:11-12, pages 1253-1269.
Crossref
Crossref
R.C. Spiller. (2004) Inflammation as a basis for functional GI disorders. Best Practice & Research Clinical Gastroenterology 18:4, pages 641-661.
Crossref
Crossref
Robin C. Spiller. (2004) Irritable bowel syndrome. British Medical Bulletin 72:1, pages 15-29.
Crossref
Crossref
Nicholas J. Talley. (2003) Evaluation of drug treatment in irritable bowel syndrome. British Journal of Clinical Pharmacology 56:4, pages 362-369.
Crossref
Crossref
RC Spiller. (2003) Infection as a cause of irritable bowel syndrome. Hospital Medicine 64:5, pages 270-274.
Crossref
Crossref
Fred M. Howard. (2003) Chronic Pelvic Pain. Obstetrics & Gynecology 101:3, pages 594-611.
Crossref
Crossref
J. G. Rosemore & Brian E. Lacy. (2002) Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 35:Supplement, pages S37-S44.
Crossref
Crossref
Rebecca C. Dunphy & G. Nicholas Verne. (2001) Drug Treatment Options for Irritable Bowel Syndrome. Drugs & Aging 18:3, pages 201-211.
Crossref
Crossref
G. Ragnarsson & G. Bodemar. (2001) Treatment of irritable bowel syndrome with loperamide oxide. An open study to determine optimal dosage. Journal of Internal Medicine 248:2, pages 165-166.
Crossref
Crossref
Elizabeth O'Keefe & Nicholas J. Talley. (1991) The Irritable Bowel Syndrome in the Elderly. Gastroenterology Clinics of North America 20:2, pages 369-390.
Crossref
Crossref
Elizabeth O’Keefe & Nicholas J. Talley. (1991) Irritable Bowel Syndrome in the Elderly. Clinics in Geriatric Medicine 7:2, pages 265-286.
Crossref
Crossref
Kenneth B. Klein. (1988) Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology 95:1, pages 232-241.
Crossref
Crossref